N/A
N=52
Ultrasound Guided Adductor Canal Versus Femoral Nerve Blocks for Anterior Cruciate Ligament Reconstruction in Pediatrics
Post-operative Pain · Quadriceps Muscle Strength
Bottom Line
View on ClinicalTrials.gov: NCT03053401 ↗Enrolled (actual)
52
Serious AEs
—
Results posted
Dec 2020
Primary outcome: Primary: Quadriceps Muscle Strength in Kilogram-force (Kgf) — 1.1; 0.0 Kilogram-force (Kgf) — p=0.026
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Adductor Canal Block (Procedure); Femoral Nerve Block (Procedure); Ultrasound (Device); Stimuplex A needle (Device); local anaesthetic injection (Drug); Steroid Drug (Drug)
- Age
- Pediatric, Adult · 8+ yrs
- Sex
- All
- Sponsor
- Akron Children's Hospital
- Primary completion
- Oct 2019
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Quadriceps Muscle Strength in Kilogram-force (Kgf) |
1.1; 0.0 | 0.026 sig |
| PRIMARY Post-operative Pain Scores Using the Numeric Pain Scoring System (NS) |
4.5; 4.5; 5.0; 6.0 | 0.762 |
| PRIMARY Total Opioid Consumption at 24 Hours Post-block |
28.9; 26.9 | 0.454 |
Summary
Both Ultrasound guided Adductor Canal Block ( ACB) and Femoral Nerve Block (FNB) has been used to provide postoperative analgesia for knee surgeries. To the investigators' knowledge, no comparison has been made between those blocks in relation to postoperative quadriceps muscle strength, or duration and quality of postoperative analgesia for arthroscopic ACL reconstruction in pediatrics. If ACB provides postoperative analgesia after arthroscopic knee surgery comparable to FNB, it has the potential to improve the postoperative outcome as it will lead to less quadriceps muscle weakness and early mobilization, both of which are very important in the early postoperative period.
Eligibility Criteria
Inclusion Criteria
- ASA I or II
- Age 8 to 18 years
- All research subjects must have an acceptable legally authorized representative capable of giving consent on the subject's behalf.
Exclusion Criteria
- Those who were unable to use a standard 0-10 NS
- Infection at the site of the block
- Bleeding disorders
- Allergy to the drugs used to perform the block ( ropivacaine , methylprednisolone)
- Those who refused a nerve block or enrollment in the study.
Data sourced from ClinicalTrials.gov (NCT03053401). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.